Mark Hyman Rapaport

21.3k total citations · 3 hit papers
194 papers, 10.5k citations indexed

About

Mark Hyman Rapaport is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Pharmacology. According to data from OpenAlex, Mark Hyman Rapaport has authored 194 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Psychiatry and Mental health, 55 papers in Experimental and Cognitive Psychology and 51 papers in Pharmacology. Recurrent topics in Mark Hyman Rapaport's work include Treatment of Major Depression (49 papers), Tryptophan and brain disorders (39 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (38 papers). Mark Hyman Rapaport is often cited by papers focused on Treatment of Major Depression (49 papers), Tryptophan and brain disorders (39 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (38 papers). Mark Hyman Rapaport collaborates with scholars based in United States, Canada and Brazil. Mark Hyman Rapaport's co-authors include Brian J. Miller, David R. Goldsmith, Lewis L. Judd, Cathryn M. Clary, Jean Endicott, Martin P. Paulus, Rana Fayyad, John R. Kelsoe, Pamela J. Schettler and Catherine Bresee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

Mark Hyman Rapaport

188 papers receiving 10.0k citations

Hit Papers

A meta-analysis of blood ... 2005 2026 2012 2019 2016 2005 2020 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
    2016 1.2k citations Mark Hyman Rapaport, Brian J. Miller et al. Molecular Psychiatry profile →
  2. Quality-of-Life Impairment in Depressive and Anxiety Disorders
    2005 715 citations Mark Hyman Rapaport et al. profile →
  3. Diet, Stress and Mental Health
    2020 247 citations Mark Hyman Rapaport et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Hyman Rapaport United States 51 3.2k 2.7k 2.2k 2.1k 1.7k 194 10.5k
Arun Ravindran Canada 53 3.8k 1.2× 1.8k 0.7× 1.9k 0.9× 2.6k 1.2× 3.3k 2.0× 192 10.8k
Isabella Heuser Germany 62 3.6k 1.1× 1.9k 0.7× 1.8k 0.8× 2.0k 1.0× 1.9k 1.2× 296 12.6k
Anthony J. Cleare United Kingdom 56 3.3k 1.0× 2.8k 1.0× 1.9k 0.8× 2.0k 1.0× 2.1k 1.3× 220 11.4k
Anne Farmer United Kingdom 56 3.5k 1.1× 1.6k 0.6× 1.7k 0.8× 2.5k 1.2× 1.1k 0.7× 191 10.0k
Julien Mendlewicz Belgium 59 4.7k 1.5× 2.2k 0.8× 2.6k 1.2× 2.5k 1.2× 3.0k 1.8× 386 13.1k
Volker Arolt Germany 62 2.7k 0.8× 3.4k 1.2× 2.1k 1.0× 1.9k 0.9× 1.0k 0.6× 251 12.0k
Witte J.G. Hoogendijk Netherlands 59 1.7k 0.5× 2.7k 1.0× 2.1k 1.0× 2.1k 1.0× 1.0k 0.6× 208 11.7k
Elisa Brietzke Brazil 56 4.3k 1.4× 4.4k 1.6× 1.2k 0.5× 2.2k 1.0× 1.1k 0.7× 274 12.1k
Janusz Rybakowski Poland 53 5.9k 1.9× 2.6k 0.9× 1.0k 0.5× 1.6k 0.8× 1.3k 0.8× 466 11.3k
Maj Vinberg Denmark 47 4.6k 1.4× 2.1k 0.8× 1.7k 0.8× 1.9k 0.9× 1.0k 0.6× 281 9.3k

Countries citing papers authored by Mark Hyman Rapaport

Since Specialization
Citations

This map shows the geographic impact of Mark Hyman Rapaport's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hyman Rapaport with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hyman Rapaport more than expected).

Fields of papers citing papers by Mark Hyman Rapaport

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hyman Rapaport. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hyman Rapaport. The network helps show where Mark Hyman Rapaport may publish in the future.

Co-authorship network of co-authors of Mark Hyman Rapaport

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hyman Rapaport. A scholar is included among the top collaborators of Mark Hyman Rapaport based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hyman Rapaport. Mark Hyman Rapaport is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Brian J., Henrique Lemos, Nina R. Schooler, et al.. (2023). Longitudinal study of inflammation and relapse in schizophrenia. Schizophrenia Research. 252. 88–95. 7 indexed citations
2.
Lamon‐Fava, Stefania, Minying Liu, Boadie W. Dunlop, et al.. (2023). Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators. Neuropsychopharmacology. 48(6). 929–935. 22 indexed citations
3.
Lamon‐Fava, Stefania, Jisun So, David Mischoulon, et al.. (2020). Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. Prostaglandins Leukotrienes and Essential Fatty Acids. 164. 102219–102219. 47 indexed citations
4.
Kinkead, Becky, et al.. (2018). Model structure for protocol adherence utilizing a manualized therapeutic massage intervention. Journal of Complementary and Integrative Medicine. 16(2). 5 indexed citations
5.
Rapaport, Mark Hyman, Andrew A. Nierenberg, Pamela J. Schettler, et al.. (2015). Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study. Molecular Psychiatry. 21(1). 71–79. 212 indexed citations
6.
Mischoulon, David, et al.. (2014). A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression. The Journal of Clinical Psychiatry. 76(1). 54–61. 58 indexed citations
7.
IsHak, Waguih William, et al.. (2012). A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting. Quality of Life Research. 22(3). 585–596. 73 indexed citations
8.
Rapaport, Mark Hyman, Pamela J. Schettler, & Catherine Bresee. (2012). A Preliminary Study of the Effects of Repeated Massage on Hypothalamic–Pituitary–Adrenal and Immune Function in Healthy Individuals: A Study of Mechanisms of Action and Dosage. The Journal of Alternative and Complementary Medicine. 18(8). 789–797. 64 indexed citations
9.
IsHak, Waguih William, Jared M. Greenberg, Jessica Jeffrey, et al.. (2011). Quality of Life: The Ultimate Outcome Measure of Interventions in Major Depressive Disorder. Harvard Review of Psychiatry. 19(5). 229–239. 200 indexed citations
10.
Gertsik, Lev, Russell E. Poland, Catherine Bresee, & Mark Hyman Rapaport. (2011). Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder. Journal of Clinical Psychopharmacology. 32(1). 61–64. 129 indexed citations
11.
Rapaport, Mark Hyman, Pamela J. Schettler, & Catherine Bresee. (2010). A Preliminary Study of the Effects of a Single Session of Swedish Massage on Hypothalamic–Pituitary–Adrenal and Immune Function in Normal Individuals. The Journal of Alternative and Complementary Medicine. 16(10). 1079–1088. 67 indexed citations
12.
Rapaport, Mark Hyman. (2009). Future Drugs for the Treatment of Depression: The Need to Look Beyond Monoamine Systems. CNS Spectrums. 14(S5). 14–16. 3 indexed citations
13.
IsHak, Waguih William, Michael C. Davis, Jessica Jeffrey, et al.. (2009). The role of dopaminergic agents in improving quality of life in major depressive disorder. Current Psychiatry Reports. 11(6). 503–508. 17 indexed citations
14.
Marangell, Lauren B., Ellen B. Dennehy, Sachiko Miyahara, et al.. (2008). The functional impact of subsyndromal depressive symptoms in bipolar disorder: Data from STEP-BD. Journal of Affective Disorders. 114(1-3). 58–67. 85 indexed citations
15.
Shelton, Richard C., Kirsten Haman, Mark Hyman Rapaport, et al.. (2006). A Randomized, Double-Blind, Active-Control Study of Sertraline Versus Venlafaxine XR in Major Depressive Disorder. The Journal of Clinical Psychiatry. 67(11). 1674–1681. 39 indexed citations
16.
Rapaport, Mark Hyman, Georges M. Gharabawi, Carla M. Canuso, et al.. (2006). Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation. Neuropsychopharmacology. 31(11). 2505–2513. 104 indexed citations
17.
Haynes, Patricia L., John R. McQuaid, John R. Kelsoe, Mark Hyman Rapaport, & J. Christian Gillin. (2004). Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals. Journal of Affective Disorders. 83(2-3). 253–262. 8 indexed citations
18.
Moore, Polly, J. Christian Gillin, Hans‐Peter Landolt, Mark Hyman Rapaport, & John R. Kelsoe. (2001). The Mood-Lowering Effect of Tryptophan Depletion: Possible Explanation for Discrepant Findings—Reply. Archives of General Psychiatry. 58(2). 201–201. 2 indexed citations
19.
Gillin, J. Christian, et al.. (2001). An Open-Label, 12-Week Clinical and Sleep EEG Study of Nefazodone in Chronic Combat-Related Posttraumatic Stress Disorder. The Journal of Clinical Psychiatry. 62(10). 789–796. 42 indexed citations
20.
Rapaport, Mark Hyman. (1999). Immune parameters in rapid cycling bipolar patients before and after lithium treatment. Journal of Psychiatric Research. 33(4). 335–340. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arun Ravindran Breakdown of academic impact, for papers by Isabella Heuser Breakdown of academic impact, for papers by Anthony J. Cleare Breakdown of academic impact, for papers by Anne Farmer Breakdown of academic impact, for papers by Julien Mendlewicz Breakdown of academic impact, for papers by Volker Arolt Breakdown of academic impact, for papers by Witte J.G. Hoogendijk Breakdown of academic impact, for papers by Elisa Brietzke Breakdown of academic impact, for papers by Janusz Rybakowski Breakdown of academic impact, for papers by Maj Vinberg
Rankless by CCL
2026